Sero-prevalence and risk factors for hepatitis B virus infection among health care workers in a tertiary hospital in Uganda

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Ziraba, Abdhalah K ^a,b   Bwogi, Josephine ^c   Namale, Alice ^d   Wainaina, Caroline W ^e   Mayanja Kizza, Harriet ^f  

^a AFRICAN POPULATION AND HEALTH RESEARCH CENTER   (Kenya)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^d MULAGO HOSPITAL   (Uganda)

^e Institute of Tropical Medicine and Infectious Diseases (ITROMID)   (Kenya)

^f MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS B VACCINE; HEPATITIS C ANTIGEN; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; DEMOGRAPHY; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOVE; HEALTH CARE PERSONNEL; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MUCOSA; NEEDLESTICK INJURY; NURSING ASSISTANT; RELIGION; RISK FACTOR; SEROPREVALENCE; STRUCTURED QUESTIONNAIRE; TERTIARY HEALTH CARE; UGANDA; VACCINATION; WORKPLACE; BLOOD; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; MIDDLE AGED; QUESTIONNAIRE; TEACHING HOSPITAL;

ADULT; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH PERSONNEL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; UGANDA;

EID: 77953955778     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-191     Document Type: Article

References (29)

1. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995, (13):S47-49.
2. Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull World Health Organ 1999, 77(10):801-807. 2557740, 10593027.
3. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004, 38(10 Suppl 3):S158-168. 10.1097/00004836-200411003-00008, 15602165.
4. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005, 34(6):1329-1339. 10.1093/ije/dyi206, 16249217.
5. World Health Organization (WHO) (ed) Hepatitis B. 2002, Geneva, World Health Organization, Department of Communicable Disease Surveillance and Response, World Health Organization (WHO) (ed).
6. Bwogi J, Braka F, Makumbi I, Mishra V, Bakamutumaho B, Nanyunja M, Opio A, Downing R, Biryahwaho B, Lewis RF. Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. African Health Sciences 2009, 9(2). 2707048, 19652743.
7. Ministry of Health (MOH) [Uganda], ORC Macro Uganda HIV/AIDS Sero-behavioural Survey 2004-2005. 2006, Calverton, Maryland, USA: Ministry of Health and ORC Macro, Ministry of Health (MOH) [Uganda], ORC Macro.
8. West DJ. The risk of hepatitis B infection among health professionals in the United States: a review. Am J Med Sci 1984, 287(2):26-33. 10.1097/00000441-198403000-00006, 6369984.
9. Taylor R, Sladden T, Levy S, Gust I, Macaskill P, Rushworth L, Gaxibarich G. A seroepidemiological study of hepatitis B amongst Fiji health care workers. Southeast Asian J Trop Med Public Health 1991, 22(4):567-576.
10. Iserson KV, Criss EA. Hepatitis B prevalence in emergency physicians. Ann Emerg Med 1985, 14(2):119-122. 10.1016/S0196-0644(85)81071-4, 3970395.
11. Pruss-Ustun A, Rapiti E, Hutin Y. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med 2005, 48(6):482-490. 10.1002/ajim.20230, 16299710.
12. Daw MA, Siala IM, Warfalli MM, Muftah MI. Seroepidemiology of hepatitis B virus markers among hospital health care workers. Analysis of certain potential risk factors. Saudi Med J 2000, 21(12):1157-1160.
13. Karpuch J, Scapa E, Eshchar J, Waron M, Bar-Shany S, Shwartz T. Vaccination against hepatitis B in a general hospital in Israel: antibody level before vaccination and immunogenicity of vaccine. Isr J Med Sci 1993, 29(8):449-452.
14. Newsom DH, Kiwanuka JP. Needle-stick injuries in an Ugandan teaching hospital. Ann Trop Med Parasitol 2002, 96(5):517-522. 10.1179/000349802125001186, 12194713.
15. Olubuyide IO, Ola SO, Aliyu B, Dosumu OO, Arotiba JT, Olaleye OA, Odaibo GN, Odemuyiwa SO, Olawuyi F. Hepatitis B and C in doctors and dentists in Nigeria. Qjm 1997, 90(6):417-422. 10.1093/qjmed/90.6.417, 9205680.
16. Ottoni CM, Penna FJ, Oliveira CG, Souza CJ. Prevalence of serologic markers of hepatitis B in dentistry students and dentists in Belo Horizonte, Brazil. Bol Oficina Sanit Panam 1995, 118(2):108-114.
17. Talaat M, Kandeel A, El-Shoubary W, Bodenschatz C, Khairy I, Oun S, Mahoney FJ. Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt. Am J Infect Control 2003, 31(8):469-474. 10.1016/j.ajic.2003.03.003, 14647109.
18. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004, 11(2):97-107. 10.1046/j.1365-2893.2003.00487.x, 14996343.
19. Szmuness W, Stevens CE, Harley EJ, Zang EA, Taylor PE, Alter HJ. The immune response of healthy adults to a reduced dose of hepatitis B vaccine. J Med Virol 1981, 8(2):123-129. 10.1002/jmv.1890080206, 7299378.
20. Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1981, 1(5):377-385. 10.1002/hep.1840010502, 7030902.
21. Nasir K, Khan KA, Kadri WM, Salim S, Tufail K, Sheikh HZ, Ali SA. Hepatitis B vaccination among health care workers and students of a medical college. J Pak Med Assoc 2000, 50(7):239-243.
22. Mahoney FJ, Stewart K, Hu H, Coleman P, Alter MJ. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med 1997, 157(22):2601-2605. 10.1001/archinte.157.22.2601, 9531229.
23. Doebbeling BN, Ferguson KJ, Kohout FJ. Predictors of hepatitis B vaccine acceptance in health care workers. Med Care 1996, 34(1):58-72. 10.1097/00005650-199601000-00005, 8551812.
24. Braka F, Nanyunja M, Makumbi I, Mbabazi W, Kasasa S, Lewis RF. Hepatitis B infection among health workers in Uganda: evidence of the need for health worker protection. Vaccine 2006, 24(47-48):6930-6937. 10.1016/j.vaccine.2006.08.029, 17027122.
25. Ganju SA, Goel A. Prevalence of HBV and HCV infection among health care workers (HCWs). J Commun Dis 2000, 32(3):228-230.
26. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005, 54(RR-16):1-31.
27. Kondili LA, Ulqinaku D, Hajdini M, Basho M, Chionne P, Madonna E, Taliani G, Candido A, Dentico P, Bino S, et al. Hepatitis B virus infection in health care workers in Albania: a country still highly endemic for HBV infection. Infection 2007, 35(2):94-97. 10.1007/s15010-007-6076-1, 17401713.
28. Ali NS, Jamal K, Qureshi R. Hepatitis B vaccination status and identification of risk factors for hepatitis B in health care workers. J Coll Physicians Surg Pak 2005, 15(5):257-260.
29. Pavli P, Bayliss GJ, Dent OF, Lunzer MR. The prevalence of serological markers for hepatitis B virus infection in Australian Naval personnel. Med J Aust 1989, 151(2):71. 74-75.